Navigation Links
Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008
Date:11/13/2008

Breakthrough Innovation Gives Greater Numbers of Pharmaceutical Scientists Access to the Power of the Xevo TQ System's Quantitative and Qualitative

Capabilities

MILFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Focused on the process of helping firms to move promising drug candidates into commercialization, Waters Corporation (NYSE: WAT) will showcase innovative UltraPerformance LC(R) (UPLC) and mass spectrometry (MS) solutions at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), November 16 - 20 in Atlanta, Georgia.

With the cost of developing and commercializing new drugs at an all-time high, there is an acute need for versatile and multitasking analytical instruments that can automate routine tasks and obtain more analytical data faster with a minimum of effort. Waters(R) goal is to allow pharmaceutical scientists to devote more precious time to value-added, problem-solving activities that lie at the heart of the drug discovery process.

Leading Waters' offerings at AAPS is the Xevo(TM) TQ MS System, an advanced tandem quadrupole mass spectrometer that allows more pharmaceutical scientists across disciplines to quickly assess the candidacy of promising new entities. Aided by the instrument's IntelliStart(TM) and ScanWave(TM) technologies, the Xevo TQ MS System produces high-quality mass spectral data at UPLC(R) acquisition speeds without sacrificing data quality. With tools like the Xevo TQ MS System, increases in information per unit of time -- and in the value of that information -- promise to greatly enhance efforts to "industrialize" the process of drug discovery on a global basis.

Waters Scientific Seminars at AAPS

Waters UPLC and MS technologies have set new standards in resolution, sensitivity and speed of analysis. To demonstrate these capabilities, Waters will host one-hour educational seminars in Hall 4C, Aisle 100, on the following topics:

-- Developing Robust Quantitative Bioanalysis Methods with Innovations in

SPE and LC/MS/MS

-- High-Sensitivity Qualitative and Quantitative LC/MS: New Possibilities

with an Easy-to use Tandem Quadrupole Mass Spectrometer

-- An Introduction to UPLC Technology

-- An Intelligent UPLC/TOF MS Workflow for Metabolite Identification

-- A Simple, Strategic Approach to Method Development

-- Maximizing Sensitivity and Flexibility in a Bioanalytical Assay with

UPLC/MS

Earlier this year the Xevo TQ MS System was recognized by Strategic Directions International's Instrument Business Outlook (IBO) newsletter when it selected the Xevo TQ MS System as the Best New Product at the 2008 American Society of Mass Spectrometry (ASMS) annual meeting in June: http://tinyurl.com/5wfehx.

"Since introducing the Xevo TQ MS System four months ago, the feedback we have received through customer demos has been outstanding," said Brian Smith, Vice President of Mass Spectrometry for the Waters Division. "Ranging from the impact of an 'intelligent' tandem quadrupole MS that automatically performs all those time consuming optimization steps normally performed manually by a skilled MS operator to the novel ScanWave technology that significantly enhances the quality of spectral data, mass spectrometer users at all levels are seeing the potential that the Xevo TQ MS System could bring to their laboratory."

Waters is now shipping the Xevo TQ MS System to customers on a worldwide basis.

For More Information

More information on Waters products at AAPS including the Synapt(TM) MS System and ACQUITY(R) UPLC System, visit Waters booth #2731 or go to: http://www.waters.com/aaps. For information on the new Xevo TQ MS System visit http://www.waters.com/xevo. For more information on Waters portfolio of LC/MS products, please visit: http://www.waters.com/ms.

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, Xevo, UltraPerformance LC, UPLC, ACQUITY, Synapt, ScanWave, and IntelliStart are trademarks of Waters Corporation.

Contact:

Brian J. Murphy

Waters Corporation

Public Relations Manager

508-482-2614

Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts
2. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
3. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
4. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
5. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
6. 2007: A Watershed Year for Lupus Research and Education
7. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
8. Waters Corporation Receives Market Leadership and Product Innovation Awards
9. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
10. Cleveland Clinic Unveils Top 10 Medical Innovations for 2009
11. Coromega Unveils New Healthy Heart and CoQ10 Supplements : Revolutionary Omega-3 Supplement Company Introduces Two Fresh Takes on Heart Health and Antioxidants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... that infants born with severe congenital diaphragmatic hernia have better survival rates if ... congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is ... pressure on the armpits, the M+D Crutch evenly distributes body weight from the elbow ... and hands when using the crutches than with other crutches. , Co-founders Max and ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)...   , Total ... Consumable Sales  Clinical sales grow 16% year-over-year  ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... first quarter ended March 31, 2016 and provided an ... commercial strategy. First Quarter 2016 Revenue Results ...
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
Breaking Medicine Technology: